Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering
Amirhossein H., Arash A., Aida N., Asadollah A., Hussein A G.
Narrative Review on Immune Modulation, published in Arch Razi Inst (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Arch Razi Inst (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41179646
- PMCID
- PMC12572674
- DOI
- 10.32592/ari.2025.80.2.313
- Citations
- 2
Abstract (original English)
Mesenchymal stem cells (MSCs) have been demonstrated to exhibit immunomodulatory properties, thereby modulating the immune response and facilitating tissue regeneration. These properties include the ability to suppress T cell proliferation, modulate macrophage polarization, and promote regulatory T cell differentiation. It has been demonstrated that natural chemoattraction pathways can attract MSCs. These cells are created from around the injured tissues, creating a repair/regenerative microenvironment for this study. The rate of tissue regeneration is contingent upon factors such as the patient's age, the extent of tissue damage, and the specific anatomical region affected. It has been demonstrated that the manipulation of mesenchymal stem cells can exert a substantial influence on the rate of tissue damage, tissue regeneration, and cell death. The immunosuppressive and trophic mechanisms under investigation are distinct from the mechanisms that are being led by tissue engineering to replace special mesenchymal tissues. Indeed, the capacity of tissue engineering processes to facilitate trophic interactions is evident, thereby promoting remarkable tissue regeneration and ensuring the seamless incorporation of newly generated tissue into the body. The field of MSCs has been a subject of study for over two decades, and recent advancements have begun to unlock their full potential
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol